Increased reduction of dimethylarginines and lowered interdialytic blood pressure by the use of biocompatible membranes

Kidney International, Supplement

Volumn 59, Issue 78, 2001, Pages S19-S24

  Schröder, Matthias ^a,b,c   Riedel, Eberhard ^a,b,c   Beck, Werner ^a,b,c   Deppisch, Reinhold M ^a,b,c   Pommer, Wolfgang ^a,b,c  

^a MARTIN LUTHER KRANKENHAUS   (Germany)

^b Institute for Biochemistrtry   (Germany)

^c Gambro Research   (Germany)

Author keywords

ADMA; Diabetes; Hemodiafiltration; Hypertension; Interdialytic blood pressure; Nitric oxide; SDMA

Indexed keywords

ARGININE; BETA 2 MICROGLOBULIN; BIOMATERIAL; DRUG DERIVATIVE; HEMOGLOBIN; N,N DIMETHYLARGININE; N,N' DIMETHYLARGININE; N,N'-DIMETHYLARGININE; N,N-DIMETHYLARGININE; UREA; AMINO ACID; ARGININE DERIVATIVE; DIMETHYLARGININE; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ARTIFICIAL KIDNEY; ARTIFICIAL MEMBRANE; BLOOD; BLOOD PRESSURE; CHRONIC KIDNEY FAILURE; COMPARATIVE STUDY; DIABETIC NEPHROPATHY; FEMALE; HEMATOCRIT; HEMODIAFILTRATION; HUMAN; MALE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; RENAL REPLACEMENT THERAPY; AMINO ACID BLOOD LEVEL; BLOOD VESSEL TONE; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DIALYSIS MEMBRANE; HEART DISEASE; HEMODIALYSIS; HEMOGLOBIN DETERMINATION; HYPERTENSION; KIDNEY FAILURE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; ARGININE; BETA 2-MICROGLOBULIN; BIOCOMPATIBLE MATERIALS; BLOOD PRESSURE; DIABETIC NEPHROPATHIES; FEMALE; HEMATOCRIT; HEMODIAFILTRATION; HEMOGLOBINS; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY, ARTIFICIAL; MALE; MEMBRANES, ARTIFICIAL; MIDDLE AGED; RENAL DIALYSIS; UREA;

EID: 0035122201     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2001.59780019.x     Document Type: Article

References (16)

1. Factors associated with inadequate blood pressure control in hypertensive hemodialysis patients
2. Morbidity and mortality due to hypertension in patients with renal failure
3. Evidence for high risk of cerebral hemorrhage in chronic dialysis patients
4. Nitric oxide: Mediator, murderer, and medicine
5. The l-arginine-nitric oxide pathway
6. The effect of malnutrition on cardiovascular mortality in dialysis patients: Is 1-arginine the answer?
7. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure
8. Concentration of dimethyl-l-arginine in the plasma of patients with end-stage renal failure
9. G-dimethyl-l-arginine, a potential endogenous nitric oxide inhibitor in dialysis patients
10. Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: Relationship to treatment method and atherosclerotic disease
11. Measurement of free amino acids in human biological fluids by high-performance liquid chromatography
12. Analytik von Aminosäuren mit Fluoreszenz-HPLC
13. Microdomain structure of polymeric surfaces: Potential for improving blood treatment procedures
14. Effect of in vivo contact between blood and dialysis membranes on protein catabolism in humans
15. Middle-sized molecule fractions isolated from uremic ultrafiltrate and normal urine inhibit ingestive behaviour in the rat
16. Hemodialysis hypotension: Interaction of inhibitors, iNOS, and the interdialytic period